Cleared Traditional

K980771 - LYSONIX SUCTION LIPOPLASTY SYSTEM

K980771 is an FDA 510(k) clearance for LYSONIX SUCTION LIPOPLASTY SYSTEM, manufactured by Lysonix, Inc.. The device is a Class 2 General & Plastic Surgery device with product code QPB cleared through the Traditional 510(k) pathway after a 136-day FDA review.

K980771 · Lysonix, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1998
Decision
136d
Days
Class 2
Risk

K980771 is an FDA 510(k) clearance for the LYSONIX SUCTION LIPOPLASTY SYSTEM. Classified as System, Suction, Lipoplasty For Removal (product code QPB), Class II - Special Controls.

Submitted by Lysonix, Inc. (Carpinteria, US). The FDA issued a Cleared decision on July 13, 1998 after a review of 136 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5040 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Lysonix, Inc. devices

FDA 510(k) Submission Details - K980771

510(k) Number K980771 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 27, 1998
Decision Date July 13, 1998
Days to Decision 136 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d slower than avg
Panel avg: 115d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

QPB Device Classification - Class 2, Special Controls

Product Code QPB System, Suction, Lipoplasty For Removal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5040
Definition A Suction Lipoplasty System Is A Device Intended For The Removal Of Adipose Tissue For Purposes Of Aesthetic Body Contouring
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - QPB System, Suction, Lipoplasty For Removal

All 30
Devices cleared under the same product code (QPB) and FDA review panel - the closest regulatory comparables to K980771.
XPS STRAIGHTSHOT OR MODEL 2000 MICRODEBRIDER SYSTEM OR XPS POWERSCULPT
K992855 · Xomed, Inc. · Jan 2000
MICRO-FRANCE LIPOSUCTION CANNULAS
K992282 · Xomed, Inc. · Sep 1999
LIGHT DUTY PNEUMATIC INSTRUMENT MODEL NUMBER PAD-100, HEAVY DUTY PNEUMATIC INSTRUMENT MODEL PAD-200, LIGHT DUTY ELECTRI
K981922 · Microaire Surgical Instruments, Inc. · Dec 1998
MENTOR PATHWAY INTRODUCER/DILATOR
K981527 · Mentor Corp. · Jul 1998
PSI-TEC LIPOSUCTION ASPIRATOR
K981215 · Byron Medical · Jul 1998
LIPOPLASTY/ LIPOSUCTION ASPIRATION AND TUMESCENT INFUSION CANNULAE AND NEEDLES
K981172 · Byron Medical · Jun 1998